Prof. Sir Bruce Ponder FRCP FMedSci FRS

Emeritus Professor of Oncology at University of Cambridge


Professor Sir Bruce Ponder is Emeritus Professor of Oncology at the University of Cambridge and was the inaugural director of the Cancer Research UK Cambridge Institute (CRUKCI). He was knighted for Services to Medicine in the 2008 and was awarded the 2013 Cancer Research UK Lifetime Achievement Prize.

Professor Sir Bruce Ponder has made enormous contributions to the field of oncology, including setting up one of the first specialist clinics for families with cancer, involvement in the discovery of several genes predisposing to cancer, and advances in our understanding of how cancer develops. His group at the CRUKCI is investigating how variations in multiple genes combine to contribute to susceptibility to breast and lung cancer, with the aim to identify high risk groups for targeted cancer screening and prevention.

On joining Owlstone Medical's Scientific Advisory Board, Professor Sir Bruce Ponder said “There is a great need to detect cancer earlier, and I strongly believe that Owlstone Medical’s technology enabling non-invasive diagnosis through breath can make a big difference in our approach to cancer screening. I am excited to be contributing to the growth and future direction of Owlstone Medical.”

Are you a smart professional looking for a new challenge? We'd love to hear from you

See our vacancies